NCT05526924 2026-03-04
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
Phase 1 Recruiting
University of Chicago
AstraZeneca
Rutgers, The State University of New Jersey
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Taiho Pharmaceutical Co., Ltd.
Rutgers, The State University of New Jersey
Shanghai Jiao Tong University School of Medicine